Breakthrough for AlzeCure in the development of drugs for nerve pain

AlzeCure Pharma shows positive results from its clinical study with a new non-opioid drug candidate developed against peripheral neuropathic pain.

AlzeCure Pharma’s CEO Martin Jönsson.

New data from AlzeCure’s phase IIa study show that the drug candidate ACD440 has a significant analgesic effect on pain induced by cold and heat.

– The medical need in this area is immense, not least to find alternatives to opioids. Neuropathic pain is the single largest market segment in pain management, generating over $11 billion in annual revenues. Up to 80 percent of all patients do not get a satisfactory effect with their current treatments, said AlzeCure Pharma’s CEO Martin Jönsson.

AlzeCure is among a handful of companies in the world that develop drugs that target the TRPV1 receptor, whose discovery was awarded the 2021 Nobel Prize in Medicine. The goal is to help people who suffer from nerve pain. In many cases today, there is no other effective treatment available than opioids, which both numb the whole body and can lead to addiction and substance abuse.

A Groundbreaking for 800 New Student and Research Apartments at Campus Flemingsberg

Today, the first groundbreaking was held for Byggvesta and EQT Exeter's 800 new student and research apartments right in the knowledge-intensive Campus Flemingsberg, with the business community just outside the door.

Flemingsberg Business Community

Flemingsberg Business Community is for those who work or run businesses on campus or in Flemingsberg. We believe that anything is possible when the right people and companies come together. Within the community, we share experiences, find synergies, and stay updated about each other and the development happening on and around the campus.

We are building a stronger Business Community in Flemingsberg

We are actively collaborating with key stakeholders to strengthen the innovation ecosystem and promote entrepreneurship in Flemingsberg. A central part of our efforts involves being present alongside other important actors and creating meeting spaces to build close relationships with those who work in the area on a daily basis. We believe that exciting and new opportunities emerge when people come together and exchange ideas.